Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Chiniara Ellen Create: Alert

All | News | Filings
Date FiledTypeDescription
02/09/2023 4 Chiniara Ellen (Director) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $3.93, valued at $157.2k
01/04/2023 4 Chiniara Ellen (Chief Legal Officer) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Granted 37,500 shares @ $0
Granted 225,000 options to buy @ $24.84, valued at $5.6M
04/28/2022 4 Chiniara Ellen (Director) has filed a Form 4 on Compass Therapeutics, Inc.
Txns: Granted 45,000 options to buy @ $1.51, valued at $68k
07/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/16/2021 4 Chiniara Ellen (EVP & Chief Legal Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.
Txns: Granted 26,812 shares @ $0
Granted 27,657 shares @ $0
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/18/2020 4 Chiniara Ellen (EVP & Chief Legal Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.
Txns: Granted 37,965 shares @ $0
Paid exercise price by delivering 16,925 shares @ $157.96, valued at $2.7M
Paid exercise price by delivering 2,988 shares @ $157.96, valued at $472k
Granted 56 shares @ $95.53, valued at $5.3k
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/05/2019 4 Chiniara Ellen (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.
Txns: Granted 8,250 shares @ $0
03/04/2019 4 Chiniara Ellen (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 633 shares @ $132.92, valued at $84.1k
03/02/2018 4 Chiniara Ellen (EVP & General Counsel) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns: Granted 8,344 shares @ $0
10/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
10/18/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
09/13/2016 4 Chiniara Ellen (GC, Chief Ethics Officer&Sec) has filed a Form 4 on ALERE INC.
Txns: Exercised 6,667 restricted stock units @ $0
02/18/2016 4 Chiniara Ellen (GC, Chief Ethics Officer&Sec) has filed a Form 4 on ALERE INC.
Txns: Acquired 232 shares @ $33.2265, valued at $7.7k
Granted 21,706 options to buy @ $0
Granted 7,500 restricted stock units @ $0
Acquired 232 shares @ $33.2265, valued at $7.7k
Granted 21,706 options to buy @ $0
Granted 7,500 restricted stock units @ $0
09/02/2015 4 Chiniara Ellen (GC, Chief Ethics Officer&Sec) has filed a Form 4 on ALERE INC.
Txns: Acquired 270 shares @ $31.841, valued at $8.6k
Paid exercise price by delivering 2,166 shares @ $51.97, valued at $112.6k
Exercised 6,666 restricted stock units @ $0
03/03/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
02/27/2015 4 Chiniara Ellen (GC, Chief Ethics Officer&Sec) has filed a Form 4 on ALERE INC.
Txns: Granted 1,500 options to buy @ $36.74, valued at $55.1k
Granted 250 options to buy @ $37.42, valued at $9.4k
09/03/2014 4 Chiniara Ellen (GC, Chief Ethics Officer&Sec) has filed a Form 4 on ALERE INC.
Txns: Granted 20,000 restricted stock units @ $0
07/02/2014 4 Chiniara Ellen (GC, Chief Ethics Officer&Sec) has filed a Form 4 on ALERE INC.
Txns: Granted 5,000 options to buy @ $37.42, valued at $187.1k
03/03/2014 4 Chiniara Ellen (General Counsel and Secretary) has filed a Form 4 on ALERE INC.
Txns: Granted 11,788 options to buy @ $25.68, valued at $302.7k
02/11/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
11/02/2011 4 Chiniara Ellen (General Counsel and Secretary) has filed a Form 4 on ALERE INC.
Txns: Exercised 10,000 options to buy @ $26.06, valued at $260.6k
11/02/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
07/02/2009 4 Form 4 -- Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy